載入中
NASDAQHealthcareMedical - Specialties
最新資料
US$8.60
−US$0.03 · -0.35%
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
前收盤價
US$8.60
−US$0.03 · -0.35%
盤後
US$8.60
US$0.00 · 0.00%
10月12日 下午4:10 ET
盤中時間採用ET。市場資料可能有所延遲。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日內區間
目前US$8.60
52週區間
目前US$8.60
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
47
合理估值
情緒
56
多空交錯
風險
54
風險偏高
動能
36
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日內區間
目前US$8.60
52週區間
目前US$8.60
| 項目（USD） | 2025會計年度 |
|---|---|
| 營收 | 3204.1萬 USD |
| 銷貨成本 | 606.6萬 USD |
| 毛利 | 2597.5萬 USD |
| 研究與開發 | 651.52萬 USD |
| 銷售、一般及管理費用 | 6582.77萬 USD |
| 營業費用 | 7234.29萬 USD |
| 利息支出 | 96.74萬 USD |
| 折舊和攤銷 | 15.17萬 USD |
| 營業利益 | −4636.79萬 USD |
| 淨利 | −4649.82萬 USD |
公司資料更新於 2026年10月13日。
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI356.9萬0.00%2.3兆 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM172.34萬0.00%787.4億 USD0.19%US$277.9-0.37%
Vanguard Extended Market ETFVXF129.28萬0.00%954億 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO45.56萬0.00%139.17億 USD0.24%US$353.71-0.86%
Schwab U.S. Small-Cap ETFSCHA45.43萬0.00%218.24億 USD0.03%US$32.66-0.40%
iShares Micro-Cap ETFIWC26.14萬0.02%13.17億 USD0.60%US$181.66-0.73%
Vanguard Russell 2000 ETFVTWO13.26萬0.00%180億 USD0.06%US$112.27-0.35%
Global X - Russell 2000 ETFRSSL4萬—14.19億 USD0.08%US$108.72-0.34%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAiShares Micro-Cap ETFIWCVanguard Russell 2000 ETFVTWOGlobal X - Russell 2000 ETFRSSLAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
